Category: Prescription Drugs
Prescription Drugs market research reports by DelveInsight
-
Opioid Use Disorder (OUD) - Epidemiology Forecast–2032
Opioid Use Disorder (OUD) - Epidemiology Forecast–2032 Key Highlights Opioid use disorder is the chronic use of opioids that causes clinically significant distress or impairment. It consists of an overpowering desire to use opioids, increased opioid tolerance, and withdrawal syndrome when discontinu ... Read More
-
ADRCs Emerging Drug Insight and Market Forecast − 2032
ADRCs Emerging Drug Insight and Market Forecast − 2032 “ADRCs Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Adipose Derived Regenerative Cells (ADRCs) for chronic wounds in the seven major markets. A detailed picture of the ADRCs for chronic wounds in ... Read More
-
VOQUEZNA TRIPLE and DUAL PAKs Drug Insight and Market Forecast − 2032
VOQUEZNA TRIPLE and DUAL PAKs Drug Insight and Market Forecast − 2032 “VOQUEZNA TRIPLE and DUAL PAKs Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VOQUEZNA TRIPLE and DUAL PAKs for Helicobacter pylori (H. pylori) infection in the United States. A detailed pict ... Read More
-
Mexiletine Drug Insight and Market Forecast − 2032
Mexiletine Drug Insight and Market Forecast − 2032 “Mexiletine Drug Insight and Market Forecast – 2032” report provides comprehensive insights about mexiletine for Myotonic Dystrophy in the seven major markets. A detailed picture of the mexiletine for myotonic dystrophy in the 7MM, i.e., the United ... Read More
-
REXULTI Drug Insight and Market Forecast − 2032
REXULTI Drug Insight and Market Forecast − 2032 “REXULTI Drug Insight and Market Forecast – 2032” report provides comprehensive insights about REXULTI for schizophrenia in the seven major markets. A detailed picture of the REXULTI for schizophrenia in the 7MM, i.e., the United States, EU4 (Germany, ... Read More
-
VX-121 Emerging Drug Insight and Market Forecast − 2032
VX-121 Emerging Drug Insight and Market Forecast − 2032 “VX-121 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VX-121 for Cystic Fibrosis in the six major markets. A detailed picture of the VX-121 for cystic fibrosis in the 6MM, i.e., the United States ... Read More
-
AMO-02 Emerging Drug Insight and Market Forecast − 2032
AMO-02 Emerging Drug Insight and Market Forecast − 2032 “AMO-02 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about AMO-02 for Myotonic Dystrophy in the seven major markets. A detailed picture of the AMO-02 for myotonic dystrophy in the 7MM, i.e., the Unite ... Read More
-
LATUDA Drug Insight and Market Forecast − 2032
LATUDA Drug Insight and Market Forecast − 2032 “LATUDA Drug Insight and Market Forecast – 2032” report provides comprehensive insights about LATUDA for schizophrenia in the seven major markets. A detailed picture of the LATUDA for schizophrenia in the 7MM, i.e., the United States, EU4 (Germany, Fran ... Read More
-
LYBALVI Drug Insight and Market Forecast − 2032
LYBALVI Drug Insight and Market Forecast − 2032 “LYBALVI Drug Insight and Market Forecast – 2032” report provides comprehensive insights about LYBALVI for schizophrenia in the seven major markets. A detailed picture of the LYBALVI for schizophrenia in the 7MM, i.e., the United States, EU4 (Germany, ... Read More
-
Ampreloxetine Emerging Drug Insight and Market Forecast − 2032
Ampreloxetine Emerging Drug Insight and Market Forecast − 2032 “Ampreloxetine Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ampreloxetine for Multiple system atrophy (MSA) in the seven major markets. A detailed picture of the ampreloxetine for MSA in ... Read More
-
Cocaine Use Disorder - Epidemiology Forecast - 2032
Cocaine Use Disorder - Epidemiology Forecast - 2032 DelveInsight’s ‘Cocaine Use Disorder (CUD) - Epidemiology Forecast–2032’ report delivers an in-depth understanding of the Cocaine Use Disorder, historical and forecasted epidemiology as well as the Cocaine Use Disorder trends in the United States, ... Read More
-
Sleep Aid- Market Insights, Competitive Landscape, and Market Forecast - 2027
Sleep Aid- Market Insights, Competitive Landscape, and Market Forecast - 2027 Sleep Aids Market By Product Type (Pharmaceuticals [Prescription, Over The Counter (OTC), Herbal And Dietary Supplements], Sleep Aid Devices), By Application (Insomnia, Obstructive Sleep Apnea (OSA), Narcolepsy And Others) ... Read More
-
ENSPRYNG Emerging Drug Insight and Market Forecast − 2032
ENSPRYNG Emerging Drug Insight and Market Forecast − 2032 “ENSPRYNG Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ENSPRYNG for Generalized Myasthenia Gravis (gMG) in the seven major markets. A detailed picture of the ENSPRYNG for generalized myastheni ... Read More
-
Bimekizumab Emerging Drug Insight and Market Forecast – 2032
Bimekizumab Emerging Drug Insight and Market Forecast – 2032 “Bimekizumab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Bimekizumab for Hidradenitis Suppurativa (HS) in the 7MM. A detailed picture of the Bimekizumab for Hidradenitis Suppurativa in the ... Read More
-
COSENTYX Emerging Drug Insight and Market Forecast – 2032
COSENTYX Emerging Drug Insight and Market Forecast – 2032 COSENTYX Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about COSENTYX for Hidradenitis Suppurativa (HS) in the 7MM. A detailed picture of the COSENTYX for Hidradenitis Suppurativa in the 7MM, i.e., t ... Read More
-
Nipocalimab Emerging Drug Insight and Market Forecast − 2032
Nipocalimab Emerging Drug Insight and Market Forecast − 2032 “Nipocalimab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about nipocalimab for Generalized Myasthenia Gravis (gMG) in the seven major markets. A detailed picture of the nipocalimab for generaliz ... Read More
-
UPLIZNA Emerging Drug Insight and Market Forecast − 2032
UPLIZNA Emerging Drug Insight and Market Forecast − 2032 “UPLIZNA Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about UPLIZNA for Generalized Myasthenia Gravis (gMG) in the seven major markets. A detailed picture of the UPLIZNA for generalized myasthenia gr ... Read More
-
Povorcitinib (INCB054707) Emerging Drug Insight and Market Forecast – 2032
Povorcitinib (INCB054707) Emerging Drug Insight and Market Forecast – 2032 “Povorcitinib (INCB054707) Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Povorcitinib (INCB054707) for Hidradenitis Suppurativa (HS) in the 7MM. A detailed picture of the Povor ... Read More
-
Latozinemab (AL001) Emerging Drug Insight and Market Forecast – 2032
Latozinemab (AL001) Emerging Drug Insight and Market Forecast – 2032 “Latozinemab (AL001) Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Latozinemab (AL001) for Frontotemporal dementia (FTD) in the 7MM. A detailed picture of the Latozinemab (AL001) for ... Read More
-
Zilucoplan Emerging Drug Insight and Market Forecast − 2032
Zilucoplan Emerging Drug Insight and Market Forecast − 2032 “Zilucoplan Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about zilucoplan for Generalized Myasthenia Gravis (gMG) in the seven major markets. A detailed picture of the zilucoplan for generalized m ... Read More
-
ULTOMIRIS Market Drug Insight and Market Forecast − 2032
ULTOMIRIS Market Drug Insight and Market Forecast − 2032 “ULTOMIRIS Market Drug Insight and Market Forecast – 2032” report provides comprehensive insights about ULTOMIRIS for Generalized Myasthenia Gravis (gMG) in the seven major markets. A detailed picture of the ULTOMIRIS for generalized myastheni ... Read More
-
Batoclimab Emerging Drug Insight and Market Forecast − 2032
Batoclimab Emerging Drug Insight and Market Forecast − 2032 “Batoclimab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about batoclimab for Generalized Myasthenia Gravis (gMG) in the seven major markets. A detailed picture of the batoclimab for generalized m ... Read More
-
TAVNEOS (Avacopan) Emerging Drug Insight and Market Forecast – 2032
TAVNEOS (Avacopan) Emerging Drug Insight and Market Forecast – 2032 “TAVNEOS (Avacopan) Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about TAVNEOS (Avacopan) for Hidradenitis Suppurativa (HS) in the 7MM. A detailed picture of the TAVNEOS (Avacopan) for Hid ... Read More
-
Zunsemetinib (ATI-450) Emerging Drug Insight and Market Forecast – 2032
Zunsemetinib (ATI-450) Emerging Drug Insight and Market Forecast – 2032 “Zunsemetinib (ATI-450) Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about Zunsemetinib (ATI-450) for Hidradenitis Suppurativa (HS) in the 7MM. A detailed picture of the Zunsemetinib ( ... Read More
-
Rozanolixizumab Emerging Drug Insight and Market Forecast − 2032
Rozanolixizumab Emerging Drug Insight and Market Forecast − 2032 “Rozanolixizumab Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about rozanolixizumab for Generalized Myasthenia Gravis (gMG) in the seven major markets. A detailed picture of the rozanolixizum ... Read More
Research Assistance
